摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-Methyl-3-[6-(4-methylsulfonylphenyl)imidazo[1,2-b]pyridazin-2-yl]urea | 1191891-92-5

中文名称
——
中文别名
——
英文名称
1-Methyl-3-[6-(4-methylsulfonylphenyl)imidazo[1,2-b]pyridazin-2-yl]urea
英文别名
——
1-Methyl-3-[6-(4-methylsulfonylphenyl)imidazo[1,2-b]pyridazin-2-yl]urea化学式
CAS
1191891-92-5
化学式
C15H15N5O3S
mdl
——
分子量
345.382
InChiKey
RBDFXQWGLCJLNZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    24
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    114
  • 氢给体数:
    2
  • 氢受体数:
    5

文献信息

  • HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY ON PI3K
    申请人:Taniyama Daisuke
    公开号:US20110105457A1
    公开(公告)日:2011-05-05
    The purpose of the present invention is to provide a compound or a pharmaceutically acceptable salt thereof which inhibits the activity of PI3K to regulate many biological processes including the growth, differentiation, survival, proliferation, migration, metabolism, and the like of cells and is therefore useful for the prevention/treatment of diseases including inflammatory diseases, arteriosclerosis, vascular/circulatory diseases, cancer/tumors, immune system diseases, cell proliferative diseases, infectious diseases, and the like. This was achieved by providing a substituted 2-amino-5,6-nitrogenated fused ring compound shown in the present specification, or a pharmaceutically acceptable salt thereof.
查看更多